F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000
Release Date:
08/31/2017
... marketed as Kymriah and made by Novartis, was approved for children and young adults for an aggressive type of leukemia ...
- resource provided by the Forum Network Knowledgebase.
Search Tip: Search with " " to find exact matches.